Fast-dissolving microparticles fail to show improved oral bioavailability

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 10, 2006, Pages 1319-1326

  Wong, S M ^a   Kellaway, I W ^a   Murdan, S ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GRISEOFULVIN; SURFACTANT;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DISSOLUTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DIFFUSION; DRUG FORMULATION; HYDROPHILICITY; IN VITRO STUDY; MALE; NONHUMAN; PARTICLE SIZE; RAT; SCANNING ELECTRON MICROSCOPY;

ADMINISTRATION, ORAL; ANIMALS; ANTI-ANXIETY AGENTS; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CAPSULES; CHEMISTRY, PHARMACEUTICAL; DIAZEPAM; GELATIN; GRISEOFULVIN; INTESTINAL ABSORPTION; MALE; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POLYSORBATES; RATS; RATS, WISTAR; SOLUBILITY; SURFACE-ACTIVE AGENTS; WATER;

EID: 33750080204     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.10.0004     Document Type: Article

References (35)

1. Amidon, G. L., Lennernäs, H., Shah, V. P., Crison, J. R. (1995) A theoretical basis for a biopharmaceutics drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12: 413-420
2. Aoyagi, N., Ogata, H., Kaniwa, N., Koibuchi, M., Shibazaki, T., Ejima, A. (1982) Unavailability of griseofulvin from tablets in humans and the correlation with its dissolution rate. J. Pharm. Sci. 71: 1165-1169
3. Aoyagi, N., Ogata, H., Kaniwa, N., Ejima, A. (1985) Unavailability of indomethacin capsules in humans (II): correlation with dissolution rate. Int. J. Clin. Pharmacol. Ther. Toxicol. 23: 529-534
4. Bates, T. R., Carrigan, P. J. (1975) Apparent absorption kinetics of micronized griseofulvin after its oral administration on single- and multiple-dose regimens to rats as a corn oil-in-water emulsion and aqueous suspension. J. Pharm. Sci. 64: 1475-1481
5. Becker, L. E. (1984) Griseofulvin. Dermatol. Clin. 2: 115-120
6. Bedford, C., Busfield, D., Child, K. J., MacGregor, I., Sutherland, P., Tomich, E. G. (1960) Studies on the biological disposition of griseofulvin, an oral antifungal agent. Arch. Dermatol. 81: 735-745
7. Casey, D. L., Beihn, R. M., Digenis, G. A., Shabhu, M. B. (1976) Method for monitoring hard gelatin capsule disintegration times in humans using external scintigraphy. J. Pharm. Sci. 65: 1412-1413
8. Davey, J. R. (1982) The role of additives in precipitation processes. In: Jancic, S. J., De Jong, E. S. (eds) Industrial crystallisation. Amsterdam: North-Holland, pp 123-135
9. De Gioannis, B., Jestin, P., Subra, P. (2004) Morphology and growth control of griseofulvin recrystallised by compressed carbon dioxide as antisolvent. J. Cryst. Growth 262: 519-526
10. Florence, A. T. (1981) Drug solubilization in surfactant systems. In: Yalkowsky, S. H. (ed.) Techniques of solubilization of drugs. Marcel Dekker Inc., New York, pp 15-89
11. Florence, A. T., Attwood, D. (1998) Physiochemical principles of pharmacy. 3rd edn, Macmillan Press Ltd, London
12. Hackett, L. P., Dusci, L. J. (1978) Determination of griseofulvin in human serum using high-performance liquid chromatography. J. Chromatogr. 155: 206-208
13. Haruta, S., Kawai, K., Jinnouchi, S., Ogawara, K-I., Higaki, K., Tamura, S., Arimori, K., Kimura, T. (2001) Evaluation of absorption kinetics of orally administered theophylline in rats based on gastrointestinal transit monitoring by gamma scintigraphy. J. Pharm. Sci. 90: 464-473
14. Hu, J., Johnston, K. P., Williams III, R. O. (2003) Spray freezing into liquid (SFL) particle engineering technology to enhance dissolution of poorly soluble drugs: organic solvent versus organic/aqueous co-solvent systems. Eur. J. Pharm. Sci. 20: 295-303
15. Hunter, E., Fell, J. T., Calvert, R. T., Sharma, H. (1980) 'In vivo' disintegration of hard gelatine capsules in fasting and non-fasting subjects. Int. J. Pharm. 4: 175-183
16. Humberstone, A. J., Charman, W. N. (1997) Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Del. Rev. 25: 103-128
17. Jarmer, D. J., Lengsfeld, C. S., Anseth, K. S., Randolph, T. W. (2005) Supercritical fluid crystallisation of griseofulvin: crystal habit modification with a selective growth inhibitor. J. Pharm. Sci. 94: 2688-2702
18. Jinno, J.-I., Kamada, N., Miyake, M., Yamada, K., Mukai, T., Odomi, M., Toguchi, H., Liversidge, G. G., Higaki, K., Kimura, T. (2006) Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J. Control. Release 111: 56-64
19. Jouyban-Gharamaleki, A., Valaee, L., Barzegar-Jalali, M., Clark, B. J., Acree Jr., W. E. (1999) Comparison of various cosolvency models for calculating solute solubility in water-cosolvent mixtures. Int. J. Pharm. 177: 93-101
20. Kaus, L. C., Fell, J. T., Sharma, H., Taylor, D. C. (1984) On the intestinal transit of a single non-disintegrating object. Int. J. Pharm. 20: 315-323
21. Kim, K. H., Singh, B. N. (2002) Drug delivery - oral route. In: Swarbrick, J., Boylan, J. C. (eds) Encyclopaedia of pharmaceutical technology. Marcel Dekker Inc., New York, pp 886-909
22. 14C griseofulvin in man. J. Pharmacol. Exp. Ther. 187: 415-422
23. Lipinski, C. A. (2001) The design of drug-like properties. European Workshop presented at Advanced Chemistry Development 2001
24. Löbenberg, R., Amidon, G. L. (2000) Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm. 50: 3-12
25. Mackellar, A. J., Buckton, G., Newton, J. M., Chowdry, B. Z., Orr, C. A. (1994) The controlled crystallisation of a model powder: 1. The effects of altering the stirring rate and supersaturation profile, and the incorporation of a surfactant (Poloxamer 188). Int. J. Pharm. 112: 65-78
26. Moneghini, M., Kikic, I., Voinovich, D., Perissutti, B., Alessi, P., Cortesi, A., Princivalle, F., Solinas, D. (2003) Study of the solid state of carbamazepine after processing with gas anti-solvent technique. Eur. J. Pharm. Biopharm. 56: 281-289
27. Mosharraf, M., Nystrom, C. (1995) The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs. Int. J. Pharm. 122: 35-47
28. Ogata, H., Aoyagi, N., Shibazaki, T., Ejima, A., Takasugi, N., Mafune, E, Hayashi, T., Suwa, K. (1984) Bioavailability of nalidixic acid from uncoated tablets in humans part I: correlation with the dissolution rates of the tablets. Int. J. Clin. Pharmacol. Ther. Toxicol. 22: 175-183
29. Pouton, C. W. (2000) Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' delivery systems. Eur. J. Pharm. Sci. 11: S93-S98
30. Quintanar-Guerrero, D., Allémann, E., Fessi, H., Doelker, E. (1998) Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev. Ind. Pharm. 24: 1113-1128
31. Rodent Capsules (Size 9/9el) for Laboratory Rats & Guinea Pigs, available at http://www.torpac.com/rat.htm, last accessed 02.06.06.
32. Sarkari, M., Brown, J., Chen, X., Swinnea, S., Williams III, R. O., Johnston, K. P. (2002) Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int. J. Pharm. 243: 17-31
33. Stefen, M. (1988) Controlled precipitation: a method to produce small drug particles and increase bioavailability. J. Galen 181: 45-53
34. Townley, E. R. (1979) Griseofulvin. Analytical Profiles Drug Substances 8: 219-249
35. Turk, M., Hils, P., Helfgen, B., Schaber, K., Martin, H.-J., Wahl, M. A. (2002) Micronization of pharmaceutical substances by the Rapid Expansion of Supercritical Solutions (RESS): a promising method to improve bioavailability of poorly soluble pharmaceutical agents. J. Supercrit. Fluids 22: 75-84